Neurostimulation specialist Nexeon Medsystems Inc. is looking to bring a nanoparticle-involved twist to the current popular narrative surrounding drug-coated balloons. The Dallas-based company is developing a nanocomposite-based polymer balloon with microperforations and was awarded an SBIR grant from the NIH. The grant will fund up to $600,000 of critical preclinical research and process development activities, including the completion of a pre-IDE meeting with the FDA.